Targeting mutant p53 for cancer therapy

Por Oren, Moshe, Tal, Perry, Rotter, Varda
Publicado no Aging (Albany NY) (2016)

Pre-target oculomotor inhibition reflects temporal orienting rather than certainty

Por Tal-Perry, Noam, Yuval-Greenberg, Shlomit
Publicado no Sci Rep (2020)

Oculomotor inhibition precedes temporally expected auditory targets

Por Abeles, Dekel, Amit, Roy, Tal-Perry, Noam, Carrasco, Marisa, Yuval-Greenberg, Shlomit
Publicado no Nat Commun (2020)

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides

Por Tal, Perry, Eizenberger, Shay, Cohen, Elad, Goldfinger, Naomi, Pietrokovski, Shmuel, Oren, Moshe, Rotter, Varda
Publicado no Oncotarget (2016)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides

Por Tal, Perry, Eizenberger, Shay, Cohen, Elad, Goldfinger, Naomi, Pietrokovski, Shmuel, Oren, Moshe, Rotter, Varda
Publicado no Oncotarget (2019)

Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta

Por Madar, Shalom, Harel, Einav, Goldstein, Ido, Stein, Yan, Kogan-Sakin, Ira, Kamer, Iris, Solomon, Hilla, Dekel, Elya, Tal, Perry, Goldfinger, Naomi, Friedlander, Gilgi, Rotter, Varda
Publicado em 2013